Cleared Traditional

K870474 - INSTAJECT

K870474 is an FDA 510(k) clearance for INSTAJECT, manufactured by Pavel Jordan & Associates, Inc.. The device is a Class 2 General Hospital device with product code KZH cleared through the Traditional 510(k) pathway after a 38-day FDA review.

K870474 · Pavel Jordan & Associates, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1987
Decision
38d
Days
Class 2
Risk

K870474 is an FDA 510(k) clearance for the INSTAJECT. Classified as Introducer, Syringe Needle (product code KZH), Class II - Special Controls.

Submitted by Pavel Jordan & Associates, Inc. (Orange, US). The FDA issued a Cleared decision on March 13, 1987 after a review of 38 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.6920 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Pavel Jordan & Associates, Inc. devices

FDA 510(k) Submission Details - K870474

510(k) Number K870474 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 03, 1987
Decision Date March 13, 1987
Days to Decision 38 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
91d faster than avg
Panel avg: 129d · This submission: 38d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KZH Device Classification - Class 2, Special Controls

Product Code KZH Introducer, Syringe Needle
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.6920
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - KZH Introducer, Syringe Needle

All 32
Devices cleared under the same product code (KZH) and FDA review panel - the closest regulatory comparables to K870474.
PEN-INJECT 2.25
K954729 · Scandinavian Health , Ltd. · Jan 1996
V-CATH PERCUTANEOUS INTRODUCER KIT
K951384 · Hdc Corp. · Jun 1995
V-CATH BREAKAWAY NEEDLE INTRODUCER
K945473 · Hdc Corp. · Jan 1995
DIAMATIC, AUTOMATIC INSULIN INJECTOR
K860284 · Ulster Scientific, Inc. · Apr 1986
MONOJECT INJECTOMATIC
K832683 · Sherwood Medical Co. · Sep 1983